| August 15, 2013 | ISSUE NUMBER 313 VOL 11 |
Obamacare
No ‘One Drug, One Therapeutic Class’ for Congress
Earlier this year a new Obamacare law directed Members of Congress and their staffs to participate in the new healthcare program, effective January 1, 2014. However, Congress disagreed with this concept, and this month successfully opted out of Obamacare when the Office of Personnel Management (OPM) created a special “exception” to the law for Members and their staffs. So what exactly did the OPM propose? ...Read more
Regulatory
$20 Billion ‘Lifestyle’ Market Immune to Costly Regulations, Says Alphaeon CEO
You can’t defraud the government if you aren’t handling its money, explains Robert Grant, CEO of Alphaeon, a lifestyle healthcare company. Pharma free-market advocates take note ...Read more
Engage your physician/HCP or health consumer audience no matter what they’re up to
At eHealthcare Solutions, we strike the perfect balance of innovation, digital engagement, and reach. For great digital solutions from a different angle, call Rob Carmignani at (609) 882-8887 ext. 100 or visit  eHealthcareSolutions.com
Marketing
The Case for Content
Reaching skittish consumers through objective, story-driven information is digital marketing's hottest digit. But applying this consumer phenomenon in Big Pharma presents some unique challenges, writes Peter Houston ...Read more
Talent Management
Tackling the Skills Shortfall in Revenue Management and Profit Optimization
End-to-end revenue lifecycle management has emerged as a powerful methodology that places price and profit maximization firmly on the boardroom agenda. But as a relatively new concept, it is perhaps not surprising that there are few specialists with the all-round expertise to drive the necessary transformational change within most businesses. Yet with a clear vision from the C-suite supported by the right systems and processes, there is almost certainly a pool of talent within the existing business capable of embracing a more strategic approach to revenue management, writes Alex Rumble ...Read more
Gross-to-Net Illusion or Reality: Closing the Gap between Excel and ERP
Live Webcast: Tuesday, September 17, 2013 at 1:00 EDT
Register Free at:
 www.pharmexec.com/grosstonet
New eBook
The Best of the Successful Product Manager's Handbook Volume III
In the third volume of this four-volume set from the pages of Pharmaceutical Executive, you'll arm yourself with information and expert accounts to fortify your marketing plans against both the unexpected and the inevitable ...Read more
|
|
|
|
 //KannaLife Sciences, Inc. and Biotech Inc., joint venture partners of South Park Ventures, LLC, announced the establishment of South Park Pharmaceuticals, Inc. ([SPPI], West Hills, NY). SPPI will focus on developing, testing, marketing and selling botanical medicaments, naturopathic compounds and phyto-medical products.//Deborah DuFresne joined InnoPharma (Piscataway, NJ) as VP, Strategic Portfolio Selection and Management.//Kite Pharma (Los Angeles, CA) added Dr Ronald Levy Director of the Lymphoma Program at Stanford University, Dr Zelig Eshhar, Chairman of Immunology Research at the Tel Aviv Sourasky Medical Center, and Dr Inder Verma, Chair of Exemplary Science and American Cancer Society Professor of Molecular Biology at The Salk Institute, to its scientific advisory board.// |
|
|
|
|
|
 |
|
|
| |
|
|
 |
|
 |
What is the primary social media tool you use for drug development research?
|
|
|
|
